Trend Report · 2026-10-23 · Tech · 3 min read · By Haowu Lab

Warhound Explained: From Origins to Now

The founders behind Anduril and the dire wolf unveiled a $200M war-dog startup.

A working dog, a double helix and a suit of armor: the two founders' résumés compressed into one company.

Why it is suddenly everywhere

  1. 01

    On October 22, 2026, Warhound came out of stealth with a $200 million seed round at a $1.2 billion valuation — an unusually large launch, backed by In-Q-Tel (the CIA’s venture arm), Sequoia, 8VC, ARK Invest and Lux Capital.

  2. 02

    Fortune’s exclusive and Wired’s “Cool, cool, cool, Palmer Luckey made a genetically modified military dog startup” headline turned the launch into an instant talking point far beyond defense media.

  3. 03

    The founders’ own backstories do the viral work: Palmer Luckey sold Oculus to Facebook and built Anduril; Ben Lamm’s Colossal Biosciences announced three gene-edited “dire wolf” pups in April 2025. Warhound is where those two storylines meet.

  4. 04

    A stark supply-chain statistic anchors the pitch: more than 80% of U.S. military working dogs are bought from Europe, and fewer than half of them are ultimately judged fit for service.

The timeline

  1. 1942The K-9 Corps is born

    The U.S. Army formally establishes its war-dog program; dogs have gone into danger ahead of soldiers ever since.

  2. 2009South Korea fields cloned sniffer dogs

    The customs service deploys six cloned detection dogs — the first proof that cloning elite working dogs is operationally possible.

  3. 2017China’s first gene-edited cloned dog

    Longlong is born in Beijing, the world’s first dog produced by combining gene editing with cloning.

  4. 2019Kunxun, the cloned police dog

    Sinogene clones a top-performing Kunming police wolfdog to cut training time; by November, six cloned K-9s join Beijing police.

  5. 2025-04The dire wolf moment

    Colossal announces Romulus, Remus and Khaleesi — gray wolves with about 20 edits across 14 genes modeled on ancient dire wolf DNA. Critics note they are edited wolves, not a revived species.

  6. ~2025A conference conversation

    Lamm and Luckey meet at Peter Diamandis’ Moonshots Summit and start talking about America’s working-dog pipeline — what Lamm calls the “Captain America dog program.”

  7. 2026-10-22Warhound exits stealth

    $200M in funding, a $1.2B valuation, and former Pentagon chief data officer David Spirk as CEO. The first dogs are already biobanked and being edited.

  8. 2027–2028First litters, first deployments

    The first cloned and edited pups are expected to be born in early 2027 and to enter service within roughly two years.

The backstory

Two founders who were already headlines

Palmer Luckey built the Oculus Rift as a teenager, sold Oculus VR to Facebook for $2 billion before turning 22, was pushed out in 2017, and immediately co-founded Anduril Industries — the defense-tech company that made autonomous systems respectable in Silicon Valley. Ben Lamm co-founded Colossal Biosciences, the Dallas “de-extinction” company whose April 2025 dire wolf announcement was one of the most argued-about science stories of the decade.

Warhound began, by both men’s telling, at a conference conversation about a year before launch. Luckey — who “loved the dire wolf announcement” — raised the state of the military’s working-dog programs. Lamm dug in and found the breeding and washout numbers. Neither calls himself a co-founder: they “developed the concept,” Lamm joined the board, Luckey holds no equity, and the CEO job went to David Spirk, a former Marine who was the first chief data officer of both U.S. Special Operations Command and the Department of Defense, and an early member of Project Maven. Colossal licenses its gene-editing technology to Warhound and keeps an economic interest.

The supply-chain problem nobody memed about

Underneath the headline-friendly weirdness sits a procurement story. The U.S. military working-dog program fields more than 2,200 dog teams, yet over 80% of the dogs are purchased from European breeders — a dependence a Senate Armed Services Committee warning described as facing “skyrocketing” costs and finite overseas supply. The American Kennel Club has assessed that there is “a shortage of even mediocre quality foreign dogs available,” and the U.S. is bidding against other governments, China and Russia among them.

Then comes the washout problem. Many purchased dogs never complete training because of inherited issues — poor eyesight, cancer risk, hip dysplasia, muscle atrophy. Fewer than half of acquired dogs are judged fit for service after a roughly three-year pipeline, meaning the system buys and trains about 200 dogs to field 100. This is the gap Warhound is actually aimed at: not science-fiction super-dogs, but a reliable domestic supply of healthy ones.

Clone first, edit carefully, armor on top

Warhound’s playbook has three layers. First, biobank cells from top-performing Belgian Malinois and German Shepherds that have already completed training, then clone those proven dogs — with the caveat that “training and environment will always influence performance.” Second, targeted gene edits: screening out variants tied to career-ending inherited disease, with “enhancements” like speed, agility and olfactory performance described as future work still being scoped as “scientifically and responsibly actionable.” Third, hardware — but on the dog, not in it: Anduril supplies eye and ear protection, sensor-equipped body armor and integration with its Eagle Eye system, which the launch materials call “cybernetic Augments” so that dogs, handlers and autonomous systems operate as one team.

The business model is equally of-the-moment: a “Canine-as-a-Service” subscription in which the government buys a steady supply of trained, supported dogs rather than individual animals. Cloning partner Viagen — already owned by Colossal — handles the cloning, and the American Humane Society is lined up to certify training and place retired dogs with former handlers. The company has no signed customers yet and no quoted price per dog.

Older than it looks — and contested like it

None of the individual pieces is unprecedented. South Korea deployed six cloned customs sniffer dogs in 2009. Chinese researchers produced the world’s first gene-edited cloned dog, Longlong, in 2017, and in 2019 cloned the celebrated police dog Kunxun explicitly to shorten training pipelines. What is new is the scale, the Silicon Valley capitalization, and the explicit pairing of germline editing with defense procurement.

The skepticism arrives pre-loaded, partly from the founders’ own history. Scientists criticized Colossal’s dire wolves as gene-edited gray wolves rather than a revived species — a definitional fight Lamm waves off for dogs (“there is no way for anyone to debate the definition of a dog”). The sharper questions are the ones the launch left open: which traits beyond disease screening will be edited, who regulates germline changes in animals bred for state use, and whether “enhancement” stays health-focused. Notably, the robot-dog wave that produced machines like Unitree’s GD01 gets a direct rebuttal here: Lamm argues no machine today matches a dog’s nose or its judgment in complex environments.

Key facts

Announced
Oct 22, 2026
Funding
$200M seed
Valuation
$1.2B
CEO
David Spirk
U.S. MWD teams
2,200+
Dogs imported
80%+ from Europe
Washout rate
Over 50%
First pups expected
Early 2027

What people are saying

Called the dog “the oldest autonomous system there is,” arguing that for thousands of years dogs have gone into danger ahead of the people they protect.
FortuneBen Lamm’s emailed remarks, paraphrasedfortune.com ↗
Framed the mission around welfare as much as performance: make the dog safer, healthier and better-performing, and it will do better in the line of duty.
TechCrunchBen Lamm interview, paraphrasedtechcrunch.com ↗
Greeted the launch with open sarcasm — a “definitely not terrifying mission” to create genetically enhanced dogs for the military, law enforcement and first responders.
Wiredlaunch coverage, paraphrasedwired.com ↗

Common questions

Is Warhound making robot dogs?

No — the opposite bet. The company clones and gene-edits real dogs and puts Anduril-made armor, goggles and sensors on them. Lamm explicitly argues no machine today matches a dog’s nose or judgment in complex environments.

What exactly is being edited in the dogs?

Publicly, only one layer is concrete: screening out inherited variants tied to career-ending diseases like hip dysplasia, muscle degeneration and cancer risk. “Enhancements” such as speed, agility or a better bomb-sniffing nose are described as future plans still being evaluated for what is scientifically and responsibly actionable.

Does Palmer Luckey own the company?

No. Luckey co-developed the concept and Anduril supplies the gear, but Lamm says Luckey holds no equity. Colossal licenses its gene-editing technology to Warhound and retains an economic interest; David Spirk is CEO.

When will the first dogs actually serve?

The first batch of dogs has been biobanked and is being edited now; the first pups are expected to be born in early 2027, with the goal of entering service within roughly two years of the launch.

More reports

Sources